Kortrijk

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 1	2026-08-18	NCT06764316
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)	Advanced Metastatic Castration-resistant Prostate Cancer; Prostate Specific Membrane Antigen (PSMA) Expression	Recruiting	Phase 1	2026-07-07	NCT06217822
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies	Biochemically Recurrent Prostate Cancer	Active, not recruiting	Phase 3	2026-07-07	NCT05794906
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer	cancer, neoplasm	Active, not recruiting	Phase 3	2026-07-07	NCT04464226

Clinical trials